Adam Guenzel, PhD is the recipient of the 2021 Richard King Trainee Award. This award was instituted by the ACMG Foundation for Genetic and Genomic Medicine to encourage American Board of Medical Genetics and Genomics (ABMGG), international equivalents, or genetic counseling trainees in their careers and to foster the publication of the highest quality research in ACMG's official journal, Genetics in Medicine (GIM).
Each year the editorial board reviews all articles published in GIM by eligible trainees who were either a first or corresponding author during that year. The manuscript considered to have the most merit is selected by a committee of editorial board members.
Dr. Guenzel received the award for his published article, "The critical role of psychosine in screening, diagnosis, and monitoring of Krabbe disease," which was published online in GIM in February 2020.
Dr. Adam Guenzel is a fellow in Laboratory Genetics and Genomics at the Mayo Clinic in Rochester, Minnesota. He received his PhD from Mayo Clinic College of Medicine and Science where he also completed his fellowship in Biochemical Genetics. His research interests include clinical laboratory test development centered around reducing false positive rates in newborn screening protocols through second tier testing and development of novel biochemical and molecular assays for potential newborn screening applications.
"I am very excited to receive the 2021 Richard King Award. I would like to thank the ACMG Foundation for this honor and also recognize the collaborators that have contributed to and improved this work. Together we have enhanced testing for the diagnosis and monitoring of patients with Krabbe," said Dr. Guenzel upon receiving the award.
"Every year we are amazed at the outstanding quality of articles authored by finalists for the prestigious King award and this year was no different. We are thrilled to announce that Dr. Adam Guenzel's article was chosen as the top article by a trainee this past year, and congratulate the author for an excellent manuscript. The caliber of papers published by King awardees reflects the tremendous accomplishments of trainees in genetics and genomics," said Robert D. Steiner, MD, FAAP, FACMG, editor-in-chief of GIM.
The award is given by the ACMG Foundation and is named for Dr. Richard King in recognition of his instrumental role in creating Genetics in Medicine and serving as the first and founding editor-in-chief of the journal. Eligible trainees include those in the following programs: clinical biochemical genetics; clinical cytogenetics; laboratory genetics and genomics; clinical molecular genetics; combined internal medicine/genetics; combined pediatrics/genetics; and genetic counseling.
About the ACMG Foundation for Genetic and Genomic Medicine
The ACMG Foundation for Genetic and Genomic Medicine, a 501(c)(3) nonprofit organization, is a community of supporters and contributors who understand the importance of medical genetics and genomics in healthcare. Established in 1992, the ACMG Foundation supports the American College of Medical Genetics and Genomics (ACMG) mission to "translate genes into health." Through its work, the ACMG Foundation fosters charitable giving, promotes training opportunities to attract future medical geneticists and genetic counselors to the field, shares information about medical genetics and genomics, and sponsors important research. To learn more and support the ACMG Foundation mission to create "Better Health through Genetics" visit http://www.acmgfoundation.org.